AR and prostate carcinoma: Taxanes antagonize the androgen receptor signaling pathway in prostate cancer cells by blocking dynein-mediated protein trafficking along interphase microtubules [35], [36], and paclitaxel decreases the endocytic trafficking of epidermal growth factor receptor in lung cancer cells [37].